FAAH inhibition as a preventive treatment for migraine: A pre-clinical study

Volume: 134, Pages: 104624 - 104624
Published: Feb 1, 2020
Abstract
Fatty-acid amide hydrolase (FAAH) is an intracellular serine hydrolase that catalyzes the cleavage of endogenous fatty-acid amides, including the endocannabinoid anandamide (AEA). We previously reported that the peripherally restricted FAAH inhibitor URB937, which selectively increases AEA levels outside the central nervous system, reduces hyperalgesia and c-Fos expression in the trigeminal nucleus caudalis (TNC) and the locus coeruleus in an...
Paper Details
Title
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study
Published Date
Feb 1, 2020
Volume
134
Pages
104624 - 104624
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.